The Drug Coating Tech creates dedicated Paclitaxel deposits in the vessel tissue for subsequent release over time to ultimately reach most effective inhibition of restenosis.
Removal of commonly encountered undesirable intravascular material, such as fresh, soft thrombi, emboli or vegetation in the right atrium, right ventricle, superior vena cava, inferior vena cava, and the iliofemoral veins.
For optimal ease of insertion and high flow rates at modest arterial pressure. Featuring anti-thrombogenic Endexo Technology.
A solution to preserving a patient’s peripheral access. More resistant to platelet aggregation with Endexo Technology.
The first PICC of its kind with Endexo Technology, providing a catheter more resistant to the accumulation of blood components (platelets and thrombus).